Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKerry Regulatory News (KYGA)

Share Price Information for Kerry (KYGA)

Share Price is delayed by 15 minutes
Get Live Data
72.40    -0.10 (-0.14%)
Bid:
71.00
Ask:
74.00
Spread: 3.00 (4.225%)
Market Cap: €11.57b
KYGA Live PriceLast checked at - London Stock Exchange

Intraday Kerry Share Chart

Kerry acquires Proexcar S.A.S.

31 May 2023 14:46

RNS Number : 2119B
Kerry Group PLC
31 May 2023
 
 

31 May 2023

LEI: 635400TLVVBNXLFHWC59

 

KERRY GROUP

Kerry acquires Proexcar S.A.S.

Kerry Group plc ("Kerry"), the global taste & nutrition company, announces it has acquired 100% of the share capital of Proexcar S.A.S. ("Proexcar") for an initial consideration of US$44m subject to routine closing adjustments, with a potential additional payment of up to US$18m payable in 2025 based on achieving earn-out conditions. Located in Colombia with c. 120 employees, the company has leading natural functional systems technologies, which can deliver clean label solutions into protein applications. This acquisition strengthens Kerry's offering and leadership position within the overall LATAM meat market, while also providing a platform for strategic development within the ANDEAN region.

ENDS

 

About Kerry

Kerry is a world leading taste and nutrition partner for the food, beverage and pharmaceutical markets. We innovate with our customers to create great tasting products, with improved nutrition and functionality, while ensuring better impact for the planet. Our leading consumer insights, global RD&A team of 1,100+ food scientists and extensive global footprint enable us to solve our customers' complex challenges with differentiated solutions. At Kerry, we are driven to be our customers' most valued partner, creating a world of sustainable nutrition, and to reach over 2 billion consumers with sustainable nutrition solutions by 2030. For more information, visit www.kerry.com.

 

 

 

 

CONTACT INFORMATION

 

Investor Relations

Marguerite Larkin, Chief Financial Officer

+353 66 7182292 | investorrelations@kerry.ie

 

 

William Lynch, Head of Investor Relations

+353 66 7182292 | investorrelations@kerry.ie

 

Media

 

Catherine Keogh, Chief Corporate Affairs & Brand Officer

 

+353 45 930188 | corpaffairs@kerry.com

Website

 

www.kerry.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQXFLFXXELZBBX
Date   Source Headline
2nd Jun 20269:30 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
22nd May 20266:04 pmRNSTransaction in Own Shares
18th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSTransaction in Own Shares
1st May 202610:07 amRNSTotal Voting Rights
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 20264:58 pmRNSResult of AGM
30th Apr 20267:00 amRNSQ1 Interim Management Statement 2026
27th Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20262:40 pmRNSTotal Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 202611:13 amRNSNotice of 2026 AGM
24th Mar 20263:36 pmRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 202611:00 amRNSAnnual Financial Report
16th Mar 20261:33 pmRNSIssuance of Equity Securities
16th Mar 20261:33 pmRNSIssuance of Equity Securities
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20261:16 pmRNSDirector/PDMR Shareholding
4th Mar 20261:14 pmRNSDirector/PDMR Shareholding
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20268:23 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20265:06 pmRNSDirector/PDMR Shareholding
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 202610:13 amRNSDirector/PDMR Shareholding
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20263:28 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.